DiseaseID 12288

血栓性微血管病

disease

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab

Disease: 1Symptom: 11Target: 12Links: 23

Arranging relationship network...

Record Fields

Scalar fields from the final disease record.

Disease Id: 12288
Core Entity Id: 69781
Source Entity Count: 1
Preferred Name: Thrombotic Microangiopathies
Name Cn: 血栓性微血管病
Name Pinyin: Xue Shuan Xing Wei Xue Guan Bing
Name En: Thrombotic Microangiopathies
Name Latin
Bilingual Status: complete
Disease Type: disease
Umls Disease Type: Disease or Syndrome
Disgenet Type: disease
Mesh Class: Hemic and Lymphatic DiseasesHemic and Lymphatic Diseases; Pathological Conditions, Signs and Symptoms
Do Class: disease of anatomical entity
Hpo Class
Mesh Class Name: Hemic and Lymphatic DiseasesPathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
Hpo Class Name
Do Class Name: disease of anatomical entity
Disease Definition: NCI2016_02D:The syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation.|MSH2017_2016_08_12:Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.|CHV2011_02:a kind of blood disorder that causes blood clots to form in blood vessels around the body
Version: v1
Suppressed: No

Names

Preferred names, aliases, and source labels retained in the final schema.

Name

Thrombotic Microangiopathies

Role

preferred

Name

Congenital Thrombotic Thrombocytopenic Purpura

Role

preferred

Name

Familial Thrombotic Thrombocytopenic Purpura

Role

preferred

Name

Purpura, Thrombotic Thrombocytopenic

Role

preferred

Name

Thrombotic Thrombocytopenic Purpura, Congenital

Role

preferred

Name

MICROANGIOPATHIC HEMOLYTIC ANEMIA

Role

alias

Name

MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL

Role

alias

Name

SCHULMAN-UPSHAW SYNDROME

Role

alias

Name

THROMBOTIC MICROANGIOPATHY, FAMILIAL

Role

alias

Name

THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL

Role

alias

Name

TTP

Role

alias

Name

Thrombotic Microangiopathy

Role

alias

Name

Thrombotic Thrombocytopenic Purpura

Role

alias

Name

UPSHAW FACTOR, DEFICIENCY OF

Role

alias

Name

UPSHAW-SCHULMAN SYNDROME

Role

alias

Name

USS

Role

alias

Cross References

Trusted external identifiers retained for this final record.

Herb

HBDIS002550HBDIS013021HBDIS018578HBDIS019680

Me Sh

D011697D057049

Omim

274150

Umls

C0034155C1268935C1956258C2717961

Icd10

M31.1

Sym Map

SMDE03567SMDE07497SMDE08656SMDE12619SMDE13875

Do Class

DOID:7

Dis Ge Net

C0034155C1268935C1956258C2717961

Umls Sty

T047

Me Sh Class

C15C23

Tcmbank Disease

1717021122302249946

Itcmdb Generated

ITX-DISEASE-C4210AA35491

Attributes

Merged source attributes and domain-specific metadata.

Version

v1v2

Suppress

Do Class Name

disease of anatomical entity

Disease Type

diseasegroup

Do Disease Class

disease of anatomical entity

Umls Disease Type

Disease or Syndrome

Disease Definition

NCI2016_02D:The syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation.|MSH2017_2016_08_12:Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.|CHV2011_02:a kind of blood disorder that causes blood clots to form in blood vessels around the bodyNCI2016_NICHD_1602D:A coagulation disorder characterized by extensive formation of thrombi in small blood vessels throughout the body due to low levels of ADAMTS13 protein, and resulting in consumption of circulating platelets, which is characterized by thrombocytopenia, anemia, neurologic changes, and sometimes fever and renal dysfunction.|NCI2016_CTCAE_1602D:A disorder characterized by the presence of microangiopathic hemolytic anemia, thrombocytopenic purpura, fever, renal abnormalities and neurological abnormalities such as seizures, hemiplegia, and visual disturbances. It is an acute or subacute condition.|NCI2016_02D:A coagulation disorder characterized by extensive formation of thrombi in small blood vessels throughout the body due to low levels of ADAMTS13 protein, and resulting in consumption of circulating platelets, which is characterized by thrombocytopenia, anemia, neurologic changes, and sometimes fever and renal dysfunction.|MSH2017_2016_08_12:An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE.|CHV2011_02:a kind of blood disorder that causes blood clots to form in blood vessels around the body|CHV2011_02:a kind of blood disorder that causes blood clots to form in blood vessels around the body|CHV2011_02:a kind of blood disorder that causes blood clots to form in blood vessels around the body|CHV2011_02:a kind of blood disorder that causes blood clots to form in blood vessels around the body

Me Sh Disease Class

Hemic and Lymphatic DiseasesHemic and Lymphatic Diseases; Pathological Conditions, Signs and Symptoms

Dis Ge Net Disease Type

diseasegroup

Disease Class Name Me Sh

Hemic and Lymphatic DiseasesPathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases

Umls Semantic Type Name

Disease or Syndrome